Effects of etanercept on quality of life, fatigue, and depression in psoriasis.
Bos
Jan D
JD
Department of Dermatology, Academic Medical Centre, University of Amsterdam, 1100 DE Amsterdam, Netherlands. j.d.bos@amc.uva.nl
de Korte
John
J
D017326:Clinical Trials, Phase III as Topic; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D004311:Double-Blind Method; D000068800:Etanercept; D005221:Fatigue / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors* / Q000627:therapeutic use
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept